ByeongDeog Park - NeoPharm Chief Pres
| 092730 Stock | KRW 11,950 10.00 0.08% |
Insider
ByeongDeog Park is Chief Pres of NeoPharm LTD
| Age | 57 |
| Phone | 82 4 2863 0038 |
| Web | https://www.neopharm.co.kr |
NeoPharm Management Efficiency
The company has return on total asset (ROA) of 0.1067 % which means that it generated a profit of $0.1067 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 13.8195 %, meaning that it generated $13.8195 on every $100 dollars invested by stockholders. NeoPharm's management efficiency ratios could be used to measure how well NeoPharm manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | INSIDER Age | ||
| TaeHoon Kim | Humax Co | 54 | |
| GwangJin Lim | Sam Chun Dang | 67 | |
| DaeIn Yoon | Sam Chun Dang | 73 | |
| TaeEun Jang | Sam Chun Dang | 62 | |
| HyungGyun Jeon | Sam Chun Dang | 63 | |
| DaeWook Kim | Sam Chun Dang | 68 | |
| Chun Seok | Sam Chun Dang | N/A | |
Management Performance
| Return On Equity | 13.82 | |||
| Return On Asset | 0.11 |
NeoPharm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NeoPharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 13.82 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 153.58 B | |||
| Shares Outstanding | 7.99 M | |||
| Shares Owned By Insiders | 38.94 % | |||
| Shares Owned By Institutions | 17.81 % | |||
| Price To Earning | 42.54 X | |||
| Price To Sales | 1.56 X |
Pair Trading with NeoPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoPharm will appreciate offsetting losses from the drop in the long position's value.Moving against NeoPharm Stock
The ability to find closely correlated positions to NeoPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoPharm LTD to buy it.
The correlation of NeoPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoPharm LTD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NeoPharm Stock
NeoPharm financial ratios help investors to determine whether NeoPharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NeoPharm with respect to the benefits of owning NeoPharm security.